On 5/8, Joe and Team proudly told us a likely fina
Post# of 36568
(Total Views: 351)
Posted On: 08/06/2021 10:01:56 AM
On 5/8, Joe and Team proudly told us a likely financing deal for the Excellagen rollout (our most marketable product, which happens to have massive profit margins) was all but done, and that the money would be available "the next day" if the deal was signed.
Since then, almost 3 months ago, there has not been an update given on this financing. Why has there been no update given, if indeed this deal was signed and the rollout has begun?
In fact, a PR on that very same product was recently released to update us on the (much smaller) Malaysian opportunity. Again, given the opportunity to update us FOR FREE on any progress on the financing deal and rollout, there was no such update.
So a reasonable person is left with two lines of thinking:
1) The financing deal has been signed, the money was received "the next day", and Joe has consciously chosen to withhold this news from us, even when he could have told us as a free piggyback on a related PR, or
2) The deal has not been signed, and there has been no such progress on the rollout of Excellagen, our most valuable approved product.
This is very simply about expectations. When Joe chooses to feed us information on a deal that can bring a highly profitable and market/patient-desired product such as Excellagen back to life, he sets expectations that he will keep us informed on that deal.
If he chooses to keep us uninformed on that deal in the event it is signed and the potentially lucrative rollout moves forward, he is badly failing on meeting those expectations that he has set himself. Frankly, if it is the case that he will not or cannot update us on this deal, Joe should not have mentioned the financing opportunity at all.
And a reasonable person should not be accused of having a "hyperactive imagination" by thinking that, if a CEO announces a potential deal that can change the company but fails to give an update on that deal (again FOR FREE), the deal may not have been signed. And the flagship product may still be dead in the water.
Your comment about hyperactive imaginations is silly at best and insulting at worst. With all due respect, I could tell you that your line of thinking of "glass half full" is a glass half full of Kool Aid. But the fact is that, as we sit here holding our shares, each of us has to take at least one sip of the Kool Aid to keep rationalize our positions given the vacuum of information we are being provided.
Since then, almost 3 months ago, there has not been an update given on this financing. Why has there been no update given, if indeed this deal was signed and the rollout has begun?
In fact, a PR on that very same product was recently released to update us on the (much smaller) Malaysian opportunity. Again, given the opportunity to update us FOR FREE on any progress on the financing deal and rollout, there was no such update.
So a reasonable person is left with two lines of thinking:
1) The financing deal has been signed, the money was received "the next day", and Joe has consciously chosen to withhold this news from us, even when he could have told us as a free piggyback on a related PR, or
2) The deal has not been signed, and there has been no such progress on the rollout of Excellagen, our most valuable approved product.
This is very simply about expectations. When Joe chooses to feed us information on a deal that can bring a highly profitable and market/patient-desired product such as Excellagen back to life, he sets expectations that he will keep us informed on that deal.
If he chooses to keep us uninformed on that deal in the event it is signed and the potentially lucrative rollout moves forward, he is badly failing on meeting those expectations that he has set himself. Frankly, if it is the case that he will not or cannot update us on this deal, Joe should not have mentioned the financing opportunity at all.
And a reasonable person should not be accused of having a "hyperactive imagination" by thinking that, if a CEO announces a potential deal that can change the company but fails to give an update on that deal (again FOR FREE), the deal may not have been signed. And the flagship product may still be dead in the water.
Your comment about hyperactive imaginations is silly at best and insulting at worst. With all due respect, I could tell you that your line of thinking of "glass half full" is a glass half full of Kool Aid. But the fact is that, as we sit here holding our shares, each of us has to take at least one sip of the Kool Aid to keep rationalize our positions given the vacuum of information we are being provided.
(6)
(0)